2018 International Congress

October 5-9, 2018. Hong Kong. Abstracts are presented on the 6th, 7th, and 8th.

View by Title View Sessions

View by Date

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z

Delivery of AAV alpha synuclein to a mouse and rat provides a useful model for the assessment of anti-parkinsonian efficacy of chronic inhibition of LRRK2

R. Hodgson, T. Parkkari, T. Martinez, M. Fell, D. Bryce, T. Heikkinen, A. Nurmi, T. Bragge, M. Taavitsainen, T. Lanz, M. Baptista (Wilmington, MA, USA)
Demographic and Clinical Characteristics of Flunarizine Induced Parkinsonism: Nationwide Data Between 2000 and 2006 in Taiwan

W. Lin, CY. Wei, HJ. Chen (ChangHua, Taiwan)
Depression (BDI-II) in Parkinson’s disease: Prevalence, types, and variables associated to major, minor and subclinical depression in COPPADIS cohort

M. Aguilar, P. Pastor, M. Almeria, I. Alvarez, S. Arribas, I. Gonzalez, M. Sierra, J. Infante, A. Avila, M. Catalan, F. Alonso, C. Villanueva, L. Lopez, V. Nogueira, V. Puente, A. Crespo, J. Garcia, F. Damas, E. Pacheco, P. Martínez-Martin, D. Santos, G. Coppadis (Terrassa, Spain)
Depression and associated factors in nondemented Chinese patients with Parkinson’s disease

J. Zhu, L. Zhang (Nanjing, China)
Depression, apathy, fatigue in Parkinson with or without STN DBS

L. Al-Nakeeb, M. Panisset (Montreal, QC, Canada)
Depressive symptoms effect subjective sleep quality in Parkinson’s Disease with and or without cognitive disturbance

J. Zhu, L. Zhang (Nanjing, China)
Depressive symptoms may predict the future development of freezing of gait in patients with Parkinson’s disease: Findings from a 5-year prospective study

T. Herman, S. Shema Shiratzky, L. Arie, N. Giladi, J. Hausdorff (Tel Aviv, Israel)
Derivation and characterization of Parkinson’s disease related pattern using functional magnetic resonance imaging

W. Sako, T. Abe, S. Haji, N. Murakami, Y. Izumi, M. Harada, R. Kaji (Tokushima, Japan)
Design and Status of the BIIB054 SPARK Trial

Parkinson Study Group, A. Siderowf (NY, USA)
Design of a Pharmacokinetics Study with Multiple Doses of Accordion Pill™ Carbidopa/Levodopa in Patients with Parkinson’s disease

C. Olanow, K. Kieburtz, J. Dubow, F. Stocchi, J. Meckler, N. Navon, R. Gendreau (Sarasota, FL, USA)

Jump to: [View All] • a b c d e f g h i j k l m n o p q r s t u v w x y z